2026-09-19T17:26:33Zhttps://dspace.mit.edu/server/oai/request

oai:dspace.mit.edu:1721.1/285702026-06-06T01:03:56Zcom_1721.1_7582com_1721.1_7581com_1721.1_101402col_1721.1_131023col_1721.1_101610

Jim [James] Masters. Bellman, Attilio, 1967- Massachusetts Institute of Technology. Engineering Systems Division. Massachusetts Institute of Technology. Engineering Systems Division 2005-09-27T17:04:55Z 2005-09-27T17:04:55Z 2003 2003 http://hdl.handle.net/1721.1/28570 57456510 Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2003. Includes bibliographical references (p. 70-73). This thesis analyzes how the Auto-ID technology and information infrastructure will change the management and distribution of pharmaceutical products within the health care industry by enabling item level product traceability functionality. The complexity of the health care industry is steadily growing, due to the concurrent increase in medical knowledge, biomedical technologies, the number of medications and the age of the population. The key to ensuring the quality, integrity and availability of health care goods is the ability to track and trace individual items throughout their complete life-cycle from manufacturing to disposal. Product traceability within the Supply Chain is becoming increasingly important for pharmaceutical manufacturers because the increasing number of medications distributed worldwide has led to the proliferation of counterfeit drugs, product diversions, re-importations and grey markets. Ultimately, the increasing complexity of the pharmaceutical distribution could affect patient safety. The potential of the Auto-ID technology and information infrastructure to synchronize the information and material flow is illustrated using a case study methodology. by Attilio Bellman. M.Eng. in Logistics 100 p. 4265201 bytes 4276745 bytes application/pdf application/pdf en_US Massachusetts Institute of Technology M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 Engineering Systems Division. Product traceability in the pharmaceutical supply chain : an analysis of the auto-ID approach Thesis application/pdf false Publication unknown unknown <Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="cc58d83b-89e9-461d-8c5c-33d208529eb1"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>Product traceability in the pharmaceutical supply chain : an analysis of the auto-ID approach</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2003</PublicationDate> <Authors> <Author> <DisplayName>Bellman, Attilio, 1967-</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Massachusetts Institute of Technology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>http://dspace.mit.edu/handle/1721.1/7582</License> <Keyword>Engineering Systems Division.</Keyword> <Abstract>This thesis analyzes how the Auto-ID technology and information infrastructure will change the management and distribution of pharmaceutical products within the health care industry by enabling item level product traceability functionality. The complexity of the health care industry is steadily growing, due to the concurrent increase in medical knowledge, biomedical technologies, the number of medications and the age of the population. The key to ensuring the quality, integrity and availability of health care goods is the ability to track and trace individual items throughout their complete life-cycle from manufacturing to disposal. Product traceability within the Supply Chain is becoming increasingly important for pharmaceutical manufacturers because the increasing number of medications distributed worldwide has led to the proliferation of counterfeit drugs, product diversions, re-importations and grey markets. Ultimately, the increasing complexity of the pharmaceutical distribution could affect patient safety. The potential of the Auto-ID technology and information infrastructure to synchronize the information and material flow is illustrated using a case study methodology.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication>